15th Jun 2018 07:00
15 June 2018
WideCells Group PLC ('WideCells Group' or 'the Group')
Align Research ('Align') Initiation of Coverage
WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, is pleased to announce that following the Group's recent placing, Align Research has released an update note with a Conviction Buy stance.
The note covers the significant progress made by the Group in regulatory and commercial developments, overview of the rapidly growing stem cell market, use of funds from recently closed placing and Align's forecasts for the Group's future growth potential.
To download the full note please visit: http://www.alignresearch.co.uk/cpt-company/widecells-group/
Related Shares:
Iconic Labs